Blunted fetal growth by tenofovir in late pregnancy.
Ei
E
Kinai
Shinichi
S
Hosokawa
Hideto
H
Gomibuchi
Hiroyuki
H
Gatanaga
Yoshimi
Y
Kikuchi
Shinichi
S
Oka
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D044466:Asian People; D015519:Bone Density / Q000187:drug effects*; D005260:Female; D005317:Fetal Growth Retardation / Q000139:chemically induced*; D006679:HIV Seropositivity / Q000150:complications / Q000188:drug therapy*; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D063065:Organophosphonates / Q000009:adverse effects*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000821:virology; D000068698:Tenofovir
D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine